Trimepranol

Trimepranol: Description and Application

Trimepranol, also known by the international name metypranolol, is a beta-blocker from the pharmaceutical group of non-cardioselective drugs. It is widely used in medical practice to treat various conditions associated with functional disorders of the cardiovascular system.

Trimepranol is produced in Slovakia, the main manufacturer is Slovakpharma. This drug is available in the form of tablets, the dosage of which is 10 mg and 40 mg.

The main mechanism of action of trimepranol is the blocking of beta-adrenergic receptors, which are located in the heart and other tissues of the body. Blocking these receptors results in a decreased response to adrenaline and other sympathetic stimulants, which contributes to decreased cardiac output and lower blood pressure. Thus, trimepranol is effectively used to control hypertension (high blood pressure).

In addition, trimepranol can be used to treat various cardiovascular diseases, such as stable angina, tachycardia, arrhythmias, and the prevention of recurrent myocardial infarction in patients who have suffered an acute myocardial infarction. It can also be recommended as an additional therapy for glaucoma, as it reduces intraocular pressure.

Some side effects may occur with trimepranol, such as dizziness, fatigue, bradycardia (slow heart rate), cold extremities and sleep disturbances. Patients with asthma, bronchial obstruction, or heart failure should consult a doctor before using this drug.

Overall, trimepranol is an effective and widely used beta blocker that helps control cardiovascular disorders and related symptoms. However, self-medication with trimepranol is not recommended and its use should only be under the supervision of a physician, who will determine the optimal dosage and regimen according to the individual needs of the patient.